Amphastar pharmaceuticals receives fda approval for epinephrine pre-filled syringes

Rancho cucamonga, ca / accesswire / august 16, 2022 / amphastar pharmaceuticals, inc. (nasdaq:amph) announced that the u.s. food and drug administration ("fda") has approved the company's new drug application ("nda") for epinephrine injection usp, 1 mg/10ml (0.1 mg/ml) single dose pre-filled syringe. epinephrine injection is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.
AMPH Ratings Summary
AMPH Quant Ranking